Skip to main content

USA - Syracuse

Reseachers - USA - Syracuse

  • Stephen V. Faraone, Ph.D.

    RESEARCH GROUP LEADER

    Stephen Faraone, PhD, is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University.  He is also Senior Scientific Advisor to the Research Program Pediatric Psychopharmacology at the Massachusetts General Hospital and a lecturer at Harvard Medical School.  Prof. Faraone studies the nature and causes of mental disorders in childhood and has ongoing research in psychiatric genetics, psychopharmacology, with a current focus on machine learning approaches to these areas.

    An author on over 1000 journal articles, editorials, chapters and books, he was the eighth highest producer of High Impact Papers in Psychiatry from 1990 to 1999 as determined by the Institute for Scientific Information (ISI, Science, 2000, Vol 288, pg 959).  In 2005, ISI determined him to be the second highest cited author for Attention Deficit Hyperactivity Disorder (https://bit.ly/35Nk3Kc).  From 2014 to 2021 he has been listed as a highly cited researcher by Thomson Reuters/Clarivate Analytics.  From 2019 to 2023, his citation metrics placed him in the top 0.01% of scientists across all fields (https://bit.ly/3j3NjEG; http://bit.ly/3Gq9j8j).   Web of Science indicates, as of March 2023, that his publications have been cited 104,669 times leading to a lifetime H-Index as of March 2023 was 156 (https://www.webofscience.com/wos/author/record/923409). In 2024, expertscape's worldwide survey rated him as the top expert in ADHD and Disruptive Behavior Disorders, worldwide (https://bit.ly/3RrBh8w).   Prof. Faraone also has a strong social media prominence with 26,500 followers on Twitter and 17,113 on LinkedIn.

    Prof. Faraone is Editor for the journal Neuropsychiatric Genetics, and Program Director for www.adhdinadults.com and www.ADHDevidence.org.   He is President of the World Federation of ADHD and was a Founding Board member for the American Professional Society of ADHD and Related Disorders.  He founded the ADHD Molecular Genetics Network in the 1990s and was a founding member of the Psychiatric Genomics Consortium’s Coordinating Committee. 

    In 2002, Prof. Faraone was inducted into the CHADD Hall of Fame in recognition of outstanding achievement in medicine and education research on attention disorders.  In 2008, he received the SUNY Upstate President’s Award for Excellence and Leadership in Research.  In 2009 he was awarded Alumni Fellow status at the University of Iowa in recognition of his outstanding contributions to society and his profession. In 2010 he received the Chancellor's Award for Excellence in Scholarship and Creative Activities from the State University of New York.  In 2013, he was awarded the title of Distinguished Professor by the State University of New York, which is conferred upon faculty having achieved national or international prominence and a distinguished reputation within the individual’s chosen field. In 2018 he received the Lifetime Achievement Award from the International Society of Psychiatric Genetics and in 2019 he received the Paul Hoch Award from the American Psychopathological Association.

  • Alysa E. Doyle, PhD

    RESEARCHER

    Alysa E Doyle PhD is a licensed child and adult clinical psychologist and Associate Professor of Psychiatry at Harvard Medical school. She holds faculty appointments in the Center for Genomic Medicine (https://cgm-dev.massgeneral.org) and the Department of Psychiatry at Massachusetts General Hospital. She is the Principal Investigator of an independently funded lab that conducts research at the intersection of developmental psychopathology, pediatric neuropsychology and psychiatric genetics. Her studies aim to characterize neuropsychiatric conditions across the lifespan, improve evidence-based assessment, clarify underlying mechanisms, and map trajectories from youth to young adulthood. Her work is particularly focused on understanding how genetic influences and cognitive capacities contribute to risk and resilience, with the goal of leveraging these constructs to promote earlier identification and improved outcomes for children with behavioral, emotional and learning difficulties.

     

    Link to projects

     

    Link to publications